Won-Sik Lee

1.3k total citations
77 papers, 866 citations indexed

About

Won-Sik Lee is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Won-Sik Lee has authored 77 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 21 papers in Pathology and Forensic Medicine and 19 papers in Oncology. Recurrent topics in Won-Sik Lee's work include Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Acute Myeloid Leukemia Research (12 papers). Won-Sik Lee is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Acute Myeloid Leukemia Research (12 papers). Won-Sik Lee collaborates with scholars based in South Korea, United States and Japan. Won-Sik Lee's co-authors include Joon‐Phil Choi, Jai‐Sung Lee, Young‐Don Joo, Sae-Gwang Park, Su‐Kil Seo, Inhak Choi, Je‐Hwan Lee, Hawk Kim, Il‐Whan Choi and Jung‐Hee Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Won-Sik Lee

67 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Won-Sik Lee South Korea 15 249 180 179 172 172 77 866
S-W. Kim South Korea 17 76 0.3× 69 0.4× 45 0.3× 424 2.5× 55 0.3× 75 1.3k
Zixu Wang China 14 43 0.2× 60 0.3× 120 0.7× 41 0.2× 18 0.1× 54 562
Vesa‐Petteri Kouri Finland 17 25 0.1× 181 1.0× 52 0.3× 72 0.4× 10 0.1× 30 811
Hongmin Zhou China 15 19 0.1× 353 2.0× 35 0.2× 110 0.6× 35 0.2× 57 857
Xinlin Su China 16 32 0.1× 46 0.3× 106 0.6× 31 0.2× 27 0.2× 30 714
Donald Regula United States 19 35 0.1× 75 0.4× 197 1.1× 154 0.9× 18 0.1× 32 1.3k
Yong‐Chul Lee South Korea 18 14 0.1× 319 1.8× 56 0.3× 156 0.9× 25 0.1× 58 884
Moeed Akbar United Kingdom 18 55 0.2× 95 0.5× 27 0.2× 48 0.3× 20 0.1× 32 1.1k
Junli Ma China 10 96 0.4× 38 0.2× 22 0.1× 54 0.3× 68 0.4× 25 563
Georgi I. Wassilew Germany 22 29 0.1× 120 0.7× 34 0.2× 56 0.3× 14 0.1× 127 1.5k

Countries citing papers authored by Won-Sik Lee

Since Specialization
Citations

This map shows the geographic impact of Won-Sik Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won-Sik Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won-Sik Lee more than expected).

Fields of papers citing papers by Won-Sik Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Won-Sik Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won-Sik Lee. The network helps show where Won-Sik Lee may publish in the future.

Co-authorship network of co-authors of Won-Sik Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Won-Sik Lee. A scholar is included among the top collaborators of Won-Sik Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Won-Sik Lee. Won-Sik Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Park, Changhee, Ho Sup Lee, Ka‐Won Kang, et al.. (2024). Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature Communications. 15(1). 2776–2776. 6 indexed citations
4.
Baek, Dong Won, Han‐Seung Park, Sang Kyun Sohn, et al.. (2023). Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study. The Korean Journal of Internal Medicine. 38(5). 734–746. 5 indexed citations
5.
Jung, Eun Hee, Junshik Hong, Sung‐Yong Kim, et al.. (2022). Real-World Outcomes of Ruxolitinib in Patients With Myelofibrosis Focusing on Red Blood Cell Transfusion: A Multicenter Study From the MPN Working Party of the Korean Society of Hematology. Clinical Lymphoma Myeloma & Leukemia. 22(10). e931–e937. 1 indexed citations
6.
Song, Ik‐Chan, Deog‐Yeon Jo, Hyeoung‐Joon Kim, et al.. (2021). Clinical features and outcomes of hypocellular acute myeloid leukemia in adults. Medicine. 100(1). e24185–e24185. 1 indexed citations
7.
Lee, Ji Hyun, Sung Yong Oh, Ho Sup Lee, et al.. (2017). Pretreatment Nutritional Status and Cardiovascular Risk Factors Affect Survival of Diffuse Large B-Cell Lymphoma Patients Treated with Immunochemotherapy. Blood. 130. 2856–2856. 1 indexed citations
8.
Lee, Sung‐Hee, et al.. (2017). Mold technology with 3D printing for manufacturing of porous implant. 11(1). 30–33. 1 indexed citations
9.
Lee, Won-Sik, Hyeoung‐Joon Kim, Jee Hyun Kong, et al.. (2017). Very Early Molecular Response at 1 Month Is a Predictor of the Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors. Blood. 130. 1593–1593. 1 indexed citations
10.
Kim, Taeyun, Ho Sup Lee, Jee‐Yeong Jeong, et al.. (2017). Effect on Clinical Outcomes of Anemia and Serum Level of Ferritin in Diffuse Large B Cell Lymphoma Treated with Rituximab Combined Chemotherapy. Blood. 130. 4158–4158. 1 indexed citations
11.
Lee, Won-Sik, et al.. (2016). Optimal design for characteristics improvement of single phase line-start permanent magnet synchronous motor. International Conference on Electrical Machines and Systems. 2 indexed citations
13.
Lee, Won-Sik, et al.. (2010). Rapid Thermal Annealing of GaN EpiLayer grown by Molecular Beam Epitaxy. The Journal of the Institute of Webcasting, Internet and Telecommunication. 10(1). 7–13. 2 indexed citations
14.
Lee, Won-Sik, et al.. (2009). A study on the electrical switching properties of oxide metal. The Journal of the Institute of Webcasting, Internet and Telecommunication. 9(3). 173–178.
15.
Kim, Jeong-Kyun, et al.. (2009). Effects of Ce on Modification of Primary Silicon in Hypereutectic Al-Si Alloy. Journal of the Korea Foundry Society. 29(4). 160–164. 1 indexed citations
16.
Kim, Seok Jin, Hyo Jin Lee, Hawk Kim, et al.. (2007). Varicella Zoster Virus Reactivation with the Use of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients.. Blood. 110(11). 4843–4843.
17.
Lee, Hong‐Seok, et al.. (2002). Amylase-Producing IgG Kappa Type Multiple Myeloma. Blood Research. 37(2). 158–160. 1 indexed citations
18.
Lee, Won-Sik, et al.. (1995). Effects of Fertilization and Mulching on Yield and Quality of Peusedanum japonicum THUNBERG. Korean Journal of Medicinal Crop Science. 3(1). 16–20. 3 indexed citations
19.
Lee, Won-Sik, et al.. (1993). The Reaction of the Tripledecker Complexes, 4(CpCo)_2(C_4R_4)$ and Alkynes. Journal of the Korean Chemical Society. 37(9). 832–836. 1 indexed citations
20.
Lee, Won-Sik, et al.. (1985). 중.고등학생들의 논리적 사고력 형성에 관한 연구 I. Journal of The Korean Association For Science Education. 5(1). 1–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026